文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气消化、代谢与肾脏急症

异基因干细胞移植受者入住重症监护室后短期和长期结局改善:942例患者的回顾性纵向分析

Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients.
PubMed 文献 · Intensive Care Med · 2018-08-23
一句话结论异基因造血干细胞移植后入住ICU的患者短期和长期生存近年显著改善,出院后生存与非ICU移植患者相当。

该回顾性纵向分析纳入2000至2013年在汉诺威医学院接受移植的942例连续成人异基因造血干细胞移植患者,其中330例至少一次入住ICU。ICU入住主要原因包括急性呼吸衰竭(35%)、严重脓毒症/脓毒性休克(23%)和心脏问题(18%)。比较2000-2006年与2007-2013年两个时期,患者年龄增大(48岁 vs 52岁,p<0.005),以急性呼吸衰竭为首要入住原因的比例从43%降至30%;ICU生存率从44%升至60%(p<0.01),住院生存率从26%升至43%(p<0.01),入住ICU后1年和3年生存率分别从14%升至32%、从11%升至23%(p<0.01)。ICU入住与生存缩短明确相关(p<0.001),但ICU患者出院后5年生存率达44%,与非ICU移植患者相当。

要点

  • 异基因造血干细胞移植患者ICU入住主要原因:急性呼吸衰竭35%、严重脓毒症/脓毒性休克23%、心脏问题18%。
  • 2007-2013年较2000-2006年,ICU生存率由44%升至60%(p<0.01),住院生存率由26%升至43%(p<0.01)。
  • 入住ICU后1年生存率由14%升至32%、3年生存率由11%升至23%(p<0.01)。
  • ICU入住与生存缩短明确相关(p<0.001),但出院后5年生存率达44%,与非ICU移植患者相当。
  • 两个时期比较,患者年龄由48岁增至52岁(p<0.005),以急性呼吸衰竭为首要入住原因的比例由43%降至30%。

适用人群与场景

  • 2000至2013年在汉诺威医学院接受移植的942例连续成人异基因造血干细胞移植患者,其中330例至少一次入住ICU并纳入本回顾性研究。

研究设计与关键结果

  • 研究类型:回顾性纵向分析;样本量:942例移植患者中330例至少一次入住ICU;单中心(汉诺威医学院)。
  • ICU入住主要原因:急性呼吸衰竭35%、严重脓毒症/脓毒性休克23%、心脏问题18%。
  • ICU入住与生存缩短明确相关(p<0.001),但ICU患者出院后5年生存率达44%,与非ICU移植患者相当。
  • 两个时期比较(2000-2006 vs 2007-2013):患者年龄48岁 vs 52岁(p<0.005);以急性呼吸衰竭为首要入住原因的比例43% vs 30%。
  • ICU生存率由44%升至60%(p<0.01),住院生存率由26%升至43%(p<0.01)。
  • 入住ICU后1年生存率由14%升至32%(p<0.01),3年生存率由11%升至23%(p<0.01)。

证据类型、等级与局限

  • 证据类型:回顾性纵向分析;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,近年来危重异基因造血干细胞移植患者短期和长期生存均显著改善,且曾入住ICU并不显著影响出院后生存。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Intensive care unit (ICU) admission of allogeneic hematopoietic stem cell transplant (HSCT) recipients is associated with relatively poor outcome. Since longitudinal data on this topic remains scarce, we analyzed reasons for ICU admission as well as short- and long-term outcome of critically ill HSCT recipients.

METHODS: A total of 942 consecutive adult patients were transplanted at Hannover Medical School from 2000 to 2013. Of those, 330 patients were at least admitted once to the ICU and included in this retrospective study. To analyze time-dependent improvements, we separately compared patient characteristics as well as reasons and outcome of ICU admission for the periods 2000-2006 and 2007-2013.

RESULTS: The main reasons for ICU admission were acute respiratory failure (ARF) in 35%, severe sepsis/septic shock in 23%, and cardiac problems in 18%. ICU admission was clearly associated with shortened survival (p < 0.001), but survival of ICU patients after hospital discharge reached 44% up to 5 years and was comparable to that of non-ICU HSCT patients. When ICU admission periods were compared, patients were older (48 vs. 52 years; p < 0.005) and the percentage of ARF as leading cause for ICU admission decreased from 43% in the first to 30% in the second period. Over time ICU and hospital survival improved from 44 to 60% (p < 0.01) and from 26 to 43% (p < 0.01), respectively. The 1- and 3-year survival rate after ICU admission increased significantly from 14 to 32% and from 11 to 23% (p < 0.01).

CONCLUSIONS: Besides ARF and septic shock, cardiac events were especially a major reason for ICU admission. Both short- and long-term survival of critically ill HSCT patients has improved significantly in recent years, and survival of HSCT recipients discharged from hospital is not significantly affected by a former ICU stay.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lueck C, Stadler M, Koenecke C, et al. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med. 2018. PMID: 30141173. doi:10.1007/s00134-018-5347-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。